To decide whether functional analysis is needed in an ABA assessment, define the clinical decision and uncertainty, review existing client, indirect, direct, health, and access evidence, and ask whether experimental results could materially change action. Compare safer or less burdensome alternatives. Proceed only with qualified competence, appropriate setting, consent, assent when applicable, health review, safety and stop rules, and a defensible risk-benefit rationale.

Define the decision value

State which intervention, safety, support, referral, or assessment choice remains uncertain and how an experimental result could change it. If the result would not alter action, adding risk or burden has weak justification.

Review existing evidence

Synthesize Rhea's accessible report, indirect sources, records, descriptive observation, health and access review, measurement, prior treatment response, and conflicts. Existing evidence can support a bounded action while uncertainty remains.

Compare alternatives

Consider environmental correction, clearer observation, structured interview, record review, preference or skill assessment, interdisciplinary referral, or a lower-risk comparison. Choose the least intrusive adequate path for the question, not the most technically elaborate method.

Assess readiness

Verify practitioner competence, setting authority, staffing, health information, communication and AAC, consent, assent when applicable, privacy, protective equipment when appropriate, emergency plan, stop criteria, data system, and post-session care.

Document risk and feasibility

Describe foreseeable risks, likely benefit, severity and base rate, ability to terminate conditions rapidly, setting constraints, client preference, alternatives, and uncertainty. Payer approval or a template never supplies clinical indication or legal authority.

Record the decision

Document proceed, modify, defer, decline, or refer; evidence; qualified owner; rationale; interim support; review date; and what could reopen the decision. Give Rhea an accessible explanation without promising that any method will reveal one definitive function.

Record which new evidence would change the decision and who is responsible for obtaining it.

Protect Rhea during assessment

For Rhea, preserve AAC and other effective communication, privacy, ordinary supports, food, water, bathroom, mobility, prescribed care, rest, and emergency help. Verify health and safety before interpreting behavior. Use applicable consent and assent processes, honor withdrawal during nonemergency participation, and route medical, mental-health, protective, or acute-risk concerns to qualified systems without waiting for routine assessment completion.

Build Rhea's evidence ladder

Move from the least intrusive evidence that can answer Rhea's question toward stronger methods only when uncertainty, decision value, risk, and feasibility justify it. Separate client report, proxy report, records, descriptive observation, measurement, structured comparison, and experimental evidence. State what each source can and cannot show, which conditions it covers, and what result would change the plan.

Explain the assessment status to Rhea

Use Rhea's preferred language and communication mode to explain the current question, completed evidence, missing contexts, health and safety boundaries, uncertainty, proposed next method, and possible decisions. Invite correction, disagreement, pause, and withdrawal where applicable. Meaningful participation supports fit. Agreement with the clinician's interpretation is never a condition for communication access or appropriate care.

Build Rhea's functional-analysis necessity decision

Create one versioned functional-analysis necessity decision for the high-uncertainty assessment review. Include question, client priority, response class, settings, sources, access, health review, ordinary supports, consent and assent when applicable, privacy, sampling, opportunities, methods, comparisons, integrity, missingness, stops, adverse events, results, alternatives, uncertainty, authority, decision, client communication, revision, and next review.

Work through Rhea's example

Rhea's review cohort contains 12 assessment questions. Three meet the predeclared criteria for considering experimental analysis; nine can be answered or safely managed with existing evidence, environmental repair, referral, or further natural observation. Of the three, two clear all readiness gates and one is held for medical review. Report 3/12 consideration and 2/3 readiness, never a universal requirement rate. Preserve all planned and valid units, raw counts, denominators, source labels, access states, missing conditions, stops, corrections, versions, decisions, and open work. This fictional example demonstrates one assessment control. It supplies no universal threshold, diagnosis, functional relation, legal conclusion, treatment effect, or outcome guarantee.

Use Rhea's evidence for a bounded decision

Identify the exact decision and qualified owner before expanding assessment. For Rhea, document supporting and conflicting evidence, current protection, client preference, alternatives, further evidence, risk, feasibility, chosen method, decision, implementation test, accessible explanation, disagreement route, and review trigger. Choose the least burdensome adequate path and stop collection that cannot change action.

Review Rhea's evidence without causal shortcuts

For Rhea, show raw observations and denominators, representative coverage, direct and proxy sources, access, health context, missingness, comparisons, observer effects, alternatives, and uncertainty. Descriptive timing and co-occurrence support hypotheses. Functional claims require evidence suited to that claim and remain bounded to the tested response, participant, procedures, and conditions.

Address Rhea's main assessment risk

Treating functional analysis as mandatory can expose Rhea to unnecessary burden or risk. Avoiding it categorically can also leave an important relation unresolved when the result would change a high-stakes decision. Review definitions, client meaning, health, access, sampling, method integrity, source independence, comparison, causal scope, and authority separately. Technical terminology cannot rescue a weak, inaccessible, or unsafe assessment. A familiar protocol never substitutes for individualized indication, competence, consent, assent, and stop rules.

Choose Rhea's next assessment action

Rhea's qualified team documents the two approved designs, keeps the held question under safe interim support, and records why nine questions use other evidence paths. Record qualified owners, current safeguards, evidence or referral tasks, assessment and plan versions, due dates, validation evidence, client communication, uncertainty, and next review. Preserve the original question, evidence, and decision when the account changes. A revision adds an auditable version instead of rewriting what was observed.

Apply current assessment sources to Rhea's method

For Rhea, the CASP public summary gives high-level context for ABA treatment of autistic people. The current BACB Ethics Code addresses competence, understandable communication, client involvement, consent and assent when applicable, medical needs, assessment, referral, intervention, risk, documentation, and evaluation for covered people. BACB has no separate organizational jurisdiction. The BCBA outline is examination content and supplies no case protocol or practice authority.

Keep functional-analysis claims bounded for Rhea

For Rhea's question, Hanley's functional-assessment review discusses the broader assessment process. The Hanley, Iwata, and McCord review examines systematic experimental functional analysis. Neither makes interview, descriptive co-occurrence, or an out-of-context result universal proof. Breaux and Smith offer assent-focused guidance in an evolving evidence base. ASHA supports continuous AAC access. SAMHSA routes danger or medical emergency in the United States to 911 or the nearest emergency room.

Close Rhea's assessment review

Review the functional-analysis necessity decision with Rhea, the responsible clinician, access and operational owners, and the specialists named in the manifest. Verify that methods remain proportionate, health and communication protected, evidence sources distinct, experimental claims bounded, uncertainty visible, and decisions within authority. Keep this page draft and noindex until every required review is complete.

Related resources

Sources